http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2577295-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b02f87d2e197878d4afcda9395fbacb |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
| filingDate | 2015-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_137ea3a6dc070235b304d35daf0d62a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a1d2d339bf2605c234d5af383034357 |
| publicationDate | 2016-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2577295-C1 |
| titleOfInvention | Method for determining activation of cortisol production in pregnant women when inducing synthesis adrenocorticotropic hormone, initiated by exacerbation of cytomegalovirus infection in the gestation period |
| abstract | FIELD: medicine. n SUBSTANCE: measure the titer of antibodies to CMV, and when set to 1:1600, elevated in the peripheral blood of pregnant 5-6 weeks' gestation to ACTH 150.01±,6 ng/ml and in the third trimester to 180.50±2.50 ng/ml cortisol for 5-6 weeks' gestation to 756.80±38.67 nmol/L, and the third trimester to 1320.20±25.00 nmol/L threatens to distort the formation of placental system and fetal development. n EFFECT: invention can be used to assess the threat of violation of the formation of placental and fetal development during exacerbation of cytomegalovirus infection in the first and third trimester of gestation. n 1 cl |
| priorityDate | 2015-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.